全覆膜自膨式金属支架在慢性胰腺炎胆管狭窄治疗中具有成本效益
慢性胰腺炎患者中良性胆管狭窄发生率可达10%至30%,内镜下支架置入是标准治疗。全覆膜自膨式金属支架(FCSEMS)与多根塑料支架(MPS)疗效相似,但FCSEMS径向直径更大、所需操作更少,然而其成本效益及额外报销覆盖FCSEMS费用的影响此前未被评估。
要点
- 慢性胰腺炎患者良性胆管狭窄发生率可达10%至30%。
- 70%至80%的狭窄可通过序贯或同期放置多根塑料支架缓解。
- FCSEMS与MPS疗效相似,但FCSEMS径向直径更大且所需操作更少。
核心结论
- 原文未报告明确结论。
研究设计与样本
- 原文未报告研究设计。
主要发现
- 慢性胰腺炎患者良性胆管狭窄发生率可达10%至30%。
- 70%至80%的狭窄通过序贯或同期放置多根塑料支架缓解。
- 近期研究显示FCSEMS留置12个月与MPS疗效相似且所需ERCP更少。
关键数值与推荐
- 原文未报告关键数值与推荐。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Benign biliary strictures (BBS) develop in up to 10% to 30% of patients with chronic pancreatitis (CP).1 Endoscopic endoprosthetics via endoscopic retrograde cholangiopancreatography (ERCP) has become the standard of care for remediating these strictures. Seventy percent to eighty percent of these strictures resolve with sequential or concurrent placement of multiple plastic stents (MPS).1,2 More recently, placement of fully covered self-expanding metal stents (FCSEMS) have been shown to have similar outcomes as MPS.3-6 FCSEMS provide a larger radial diameter and require fewer procedures, but may have drawbacks, including a higher risk of migration, cholecystitis, delamination, and tissue ingrowth. A recent study demonstrated that FCSEMS with a 12-month indwell had similar outcomes to MPS with fewer ERCP needed.7 However, the cost-effectiveness of either strategy for managing BBS has not been assessed previously nor has the impact of additional reimbursement to cover the cost of FCSEMS on the cost-effectiveness of FCSEMS utilization.
引用
- Thiruvengadam NR, Saumoy M, Schneider Y, et al. Fully Covered Self-expanding Stents are Cost-effective at Remediating Biliary Strictures in Patients With Chronic Pancreatitis. Clin Gastroenterol Hepatol. 2022. PMID: 35181569. doi:10.1016/j.cgh.2022.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。